• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

欧洲皮肤病学会和性病学会:慢性瘙痒症定义、分类和术语的专家共识。

European academy of dermatology and venereology European prurigo project: expert consensus on the definition, classification and terminology of chronic prurigo.

机构信息

Department of Dermatology, Competence Center for Chronic Pruritus, University Hospital Münster, Münster, Germany.

Competence Center for Healthcare Research in Dermatology (CVderm), Institute for Healthcare Research in Dermatology and Nursing (IVDP), University Hospital of Hamburg-Eppendorf, Hamburg, Germany.

出版信息

J Eur Acad Dermatol Venereol. 2018 Jul;32(7):1059-1065. doi: 10.1111/jdv.14570. Epub 2017 Sep 22.

DOI:10.1111/jdv.14570
PMID:28857299
Abstract

BACKGROUND

The term prurigo has been used for many decades in dermatology without clear definition, and currently used terminology of prurigo is inconsistent and confusing. Especially, itch-related prurigo remains unexplored regarding the epidemiology, clinical profile, natural course, underlying causes, available treatments and economic burden, although burdensome and difficult to treat.

OBJECTIVE

To address these issues, the multicentre European Prurigo Project (EPP) was designed to increase knowledge on chronic prurigo (CPG). In the first step, European experts of the EADV Task Force Pruritus (TFP) aimed to achieve a consensus on the definition, classification and terminology of CPG. Additionally, procedures of the cross-sectional EPP were discussed and agreed upon.

METHODS

Discussions and surveys between members of the TFP served as basis for a consensus conference. Using the Delphi method, consensus was defined as an agreement ≥75% among the present members.

RESULTS

Twenty-four members of the TFP participated in the consensus conference. Experts consented that CPG should be used as an umbrella term for the range of clinical manifestations (e.g. papular, nodular, plaque or umbilicated types). CPG is considered a distinct disease defined by the presence of chronic pruritus for ≥6 weeks, history and/or signs of repeated scratching and multiple localized/generalized pruriginous skin lesions (whitish or pink papules, nodules and/or plaques). CPG occurs due to a neuronal sensitization to itch and the development of an itch-scratch cycle.

CONCLUSION

This new definition and terminology of CPG should be implemented in dermatology to harmonize communication in the clinical routine, clinical trials and scientific literature. Acute/subacute forms of prurigo are separated entities, which need to be differentiated from CPG and will be discussed in a next step. In the near future, the cross-sectional EPP will provide relevant clinical data on various aspects of CPG leading to new directions in the scientific investigation of CGP.

摘要

背景

几十年来,皮肤科一直使用瘙痒症一词,但没有明确的定义,目前使用的瘙痒症术语不一致且令人困惑。特别是,尽管瘙痒症相关的瘙痒症具有负担性且难以治疗,但在流行病学、临床特征、自然病程、潜在原因、现有治疗方法和经济负担方面仍未得到探索。

目的

为了解决这些问题,欧洲多中心瘙痒症项目(EPP)旨在增加对慢性瘙痒症(CPG)的了解。在第一步中,EADV 瘙痒症工作组(TFP)的欧洲专家旨在就 CPG 的定义、分类和术语达成共识。此外,还讨论并商定了横断面 EPP 的程序。

方法

TFP 成员之间的讨论和调查为共识会议提供了基础。使用 Delphi 方法,共识定义为出席成员之间的一致意见≥75%。

结果

TFP 的 24 名成员参加了共识会议。专家们一致认为,瘙痒症应作为一系列临床表现(如丘疹、结节、斑块或脐状型)的总称使用。CPG 被认为是一种独特的疾病,其特征为慢性瘙痒≥6 周,有反复搔抓的病史和/或迹象,以及多发性局限性/全身性瘙痒性皮肤损伤(白色或粉红色丘疹、结节和/或斑块)。CPG 是由于对瘙痒的神经元敏化以及瘙痒-搔抓循环的发展引起的。

结论

应在皮肤病学中实施 CPG 的这一定义和术语,以协调临床常规、临床试验和科学文献中的沟通。瘙痒症的急性/亚急性形式是分离的实体,需要与 CPG 区分开来,这将在下一步中进行讨论。在不久的将来,横断面 EPP 将提供关于 CPG 各个方面的相关临床数据,为 CPG 的科学研究提供新的方向。

相似文献

1
European academy of dermatology and venereology European prurigo project: expert consensus on the definition, classification and terminology of chronic prurigo.欧洲皮肤病学会和性病学会:慢性瘙痒症定义、分类和术语的专家共识。
J Eur Acad Dermatol Venereol. 2018 Jul;32(7):1059-1065. doi: 10.1111/jdv.14570. Epub 2017 Sep 22.
2
Position Statement: Linear prurigo is a subtype of chronic prurigo.立场声明:线性痒疹是慢性痒疹的一个亚型。
J Eur Acad Dermatol Venereol. 2019 Feb;33(2):263-266. doi: 10.1111/jdv.15275. Epub 2018 Oct 31.
3
How to define chronic prurigo?如何定义慢性痒疹?
Exp Dermatol. 2019 Dec;28(12):1455-1460. doi: 10.1111/exd.13972. Epub 2019 Jun 6.
4
Prurigo nodularis: a physician survey to evaluate current perceptions of its classification, clinical experience and unmet need.结节性痒疹:一项医生调查,以评估当前对其分类、临床经验和未满足需求的看法。
J Eur Acad Dermatol Venereol. 2018 Dec;32(12):2224-2229. doi: 10.1111/jdv.15107. Epub 2018 Jul 1.
5
Chronic Prurigo Including Prurigo Nodularis: New Insights and Treatments.慢性瘙痒症,包括结节性瘙痒症:新的见解和治疗方法。
Am J Clin Dermatol. 2024 Jan;25(1):15-33. doi: 10.1007/s40257-023-00818-z. Epub 2023 Sep 17.
6
Chronic Prurigo: Similar Clinical Profile and Burden Across Clinical Phenotypes.慢性痒疹:不同临床表型的相似临床特征与负担
Front Med (Lausanne). 2021 Jun 29;8:649332. doi: 10.3389/fmed.2021.649332. eCollection 2021.
7
Chronic prurigo.慢性瘙痒症。
Br J Dermatol. 2022 Oct;187(4):464-471. doi: 10.1111/bjd.21698. Epub 2022 Jul 12.
8
[Nihil certum: historical development of the term prurigo].[无定论:痒疹这一术语的历史发展]
Hautarzt. 2014 Aug;65(8):674-83. doi: 10.1007/s00105-014-2752-0.
9
EADV Task Force Pruritus White Paper on chronic pruritus and chronic prurigo: Current challenges and future solutions.EADV 瘙痒问题工作组慢性瘙痒和慢性痒疹白皮书:当前挑战与未来解决方案。
J Eur Acad Dermatol Venereol. 2024 Sep;38(9):1687-1693. doi: 10.1111/jdv.20102. Epub 2024 May 13.
10
[Prurigo. Clinical definition and classification].[痒疹。临床定义与分类]
Hautarzt. 2014 Aug;65(8):684-90. doi: 10.1007/s00105-014-2753-z.

引用本文的文献

1
Four Cases of Prurigo Nodularis Requiring Nemolizumab due to Persistent Pruritus or Lesions after Dupilumab Treatment.4例结节性痒疹在度普利尤单抗治疗后因持续性瘙痒或皮损而需要使用奈莫利单抗治疗
Acta Derm Venereol. 2025 Jun 16;105:adv43419. doi: 10.2340/actadv.v105.43419.
2
Evaluation of routine care of prurigo nodularis in Germany: retrospective chart review study (ADVANCE PN).德国结节性痒疹常规护理评估:回顾性病历审查研究(ADVANCE PN)
J Dtsch Dermatol Ges. 2025 Jul;23(7):844-855. doi: 10.1111/ddg.15721. Epub 2025 Jun 8.
3
Effectiveness of Nemolizumab in Improving Dialysis-Associated Pruritus Refractory to Difelikefalin: A Case Report.
奈莫利珠单抗治疗对双醋瑞因难治的透析相关瘙痒的有效性:一例报告
Cureus. 2025 May 2;17(5):e83367. doi: 10.7759/cureus.83367. eCollection 2025 May.
4
Successful Treatment of Upadacitinib in Prurigo Nodularis: A Case Report and Review of the Literature.乌帕替尼成功治疗结节性痒疹:一例报告及文献综述
Int Med Case Rep J. 2025 May 28;18:637-644. doi: 10.2147/IMCRJ.S514339. eCollection 2025.
5
Cutaneous Adverse Events Following Nemolizumab Administration: A Review.奈莫利珠单抗给药后的皮肤不良事件:综述
J Clin Med. 2025 Apr 27;14(9):3026. doi: 10.3390/jcm14093026.
6
Type 2 Inflammation and Its Role in Dermatologic Diseases.2型炎症及其在皮肤病中的作用。
Int J Dermatol. 2025 Jun;64(6):978-991. doi: 10.1111/ijd.17707. Epub 2025 Mar 22.
7
A Case of Erythema Multiforme Following the Administration of Nemolizumab.一例使用奈莫利珠单抗后发生的多形红斑病例。
Cureus. 2025 Feb 15;17(2):e79070. doi: 10.7759/cureus.79070. eCollection 2025 Feb.
8
The Significant Role of Atopic Skin Diathesis in Prurigo Nodularis.特应性皮肤素质在结节性痒疹中的重要作用。
Sisli Etfal Hastan Tip Bul. 2024 Dec 24;58(4):477-482. doi: 10.14744/SEMB.2024.46144. eCollection 2024.
9
Efficacy and Safety of Nemolizumab in Patients With Moderate to Severe Prurigo Nodularis: The OLYMPIA 1 Randomized Clinical Phase 3 Trial.奈莫利单抗治疗中度至重度结节性痒疹患者的疗效和安全性:OLYMPIA 1随机临床3期试验
JAMA Dermatol. 2025 Feb 1;161(2):147-156. doi: 10.1001/jamadermatol.2024.4796.
10
Treatment With Upadacitinib in Refractory Prurigo Nodularis: A Prospective Cohort Study.乌帕替尼治疗难治性结节性痒疹:一项前瞻性队列研究。
Allergy Asthma Immunol Res. 2024 Sep;16(5):546-554. doi: 10.4168/aair.2024.16.5.546.